Reed's (REED) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Net sales declined to $7.1 million in Q1 2026 from $10.0 million year-over-year, driven by lower volumes and higher promotional allowances, resulting in a 29% decrease.
Gross margin fell to 10% from 34% year-over-year, primarily due to inventory write-offs, liquidation, and increased cost per case.
Net loss widened to $6.5 million ($0.55 per share) from $2.0 million ($0.27 per share) year-over-year, with operating loss at $6.2 million versus $1.7 million.
Management initiated corrective actions early in Q1 2026 to stabilize operations, improve execution, and position for profitable growth.
Strategic investments continued in Asia Pacific expansion, though these subsidiaries did not generate material sales in the period.
Financial highlights
Net sales for Q1 2026 were $7.1 million, down from $10.0 million year-over-year, with gross billing at $8.5 million.
Gross profit was $0.7 million, an 80% drop from the prior year; cost of goods sold was $6.4 million, 90% of net sales.
SG&A expenses rose to $5.8 million from $3.5 million, mainly due to investments in personnel and marketing for Asia growth.
EBITDA was -$6.2 million, compared to -$1.7 million in Q1 2025; cash used in operations was $5.8 million.
Cash at quarter-end was $4.6 million, with total debt of $9.2 million, compared to $10.4 million cash at year-end 2025.
Outlook and guidance
Management expects sequential improvement in net sales, gross margin, and net loss starting in Q2 2026, with early signs of margin improvement and positive returns on e-commerce ad spend.
Full recovery and stabilization are anticipated by the end of Q2, with ongoing KPI tracking for sales and broker performance.
Management expects existing cash and committed financing to fund operations for at least twelve months, but additional funding may be needed for further growth initiatives.
Continued focus on product portfolio optimization, sales strategies, and operational efficiencies to improve performance.
Q1 2026 performance is not viewed as indicative of full-year expectations due to transitional factors.
Latest events from Reed's
- Annual meeting to vote on directors, auditor, equity plan, and executive pay, with board support.REED
Proxy filing29 Apr 2026 - Annual meeting to vote on directors, auditor, equity plan, and executive pay, June 10, 2026.REED
Proxy filing29 Apr 2026 - Sequential improvements and new growth initiatives set the stage for margin expansion in 2026.REED
Q4 202525 Mar 2026 - Q2 2024 saw double-digit sales growth, margin gains, and improved but still risky profitability.REED
Q2 20241 Feb 2026 - Net sales and margins dropped, but new funding and restructuring target 2025 recovery.REED
Q3 202414 Jan 2026 - Financial restructuring and product innovation set the stage for strong growth in 2025.REED
The Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Gross margin hit 30% as debt fell and new products and capital set up 2025 growth.REED
Q4 202426 Dec 2025 - Five-year warrants with cash/cashless exercise, anti-dilution, and strong investor protections.REED
Registration Filing4 Dec 2025 - IPO offers shares and warrants to fund growth amid ongoing losses and pending NYSE listing.REED
Registration Filing2 Dec 2025